Issue 5, 2011

Molecular obesity, potency and other addictions in drug discovery

Abstract

Despite the increase in global biology and chemistry knowledge the discovery of effective and safe new drugs seems to become harder rather than easier. Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learnt from our failures. This perspective reflects on some of the learnings of recent years in relation to the causes of attrition. The term Molecular Obesity is introduced to describe our tendency to build potency into molecules by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.

Graphical abstract: Molecular obesity, potency and other addictions in drug discovery

Article information

Article type
Review Article
Submitted
18 Jan 2011
Accepted
14 Feb 2011
First published
07 Mar 2011

Med. Chem. Commun., 2011,2, 349-355

Molecular obesity, potency and other addictions in drug discovery

M. M. Hann, Med. Chem. Commun., 2011, 2, 349 DOI: 10.1039/C1MD00017A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements